Colorectal Cancer Screening: Criteria, Population, and Tests
This paper examines the decision-making framework behind disease screening programs, using colorectal cancer as a primary example. It discusses the core criteria that justify initiating a screening program — including disease prevalence, the value of early detection, and the availability of reliable diagnostic tests. The paper also addresses how target populations are selected, the ethical considerations of excluding certain groups such as younger adults, and the comparative reliability of available screening tests, including colonoscopy, sigmoidoscopy, barium tests, and fecal occult tests. The role of capacity constraints and cost is also considered.
- Criteria for Initiating a Screening Program: Prevalence, early detection value, and test availability
- Selecting the Target Population: Who is targeted and why risk matters
- Ethical Considerations in Population Screening: Younger patients excluded from standard guidelines
- Test Reliability and Validity: Comparing colonoscopy, fecal occult, and other tests
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Uses colorectal cancer as a consistent, concrete example throughout, grounding abstract screening criteria in a real-world disease context.
- Moves logically from macro-level program decisions (should we screen at all?) to meso-level decisions (who should we screen?) to micro-level concerns (which test is best?), creating a coherent analytical progression.
- Raises a genuine ethical tension — the exclusion of younger, asymptomatic patients from standard screening guidelines — without overstating or resolving it too neatly.
Key academic technique demonstrated
The paper applies a multi-criteria decision framework to a public health question, systematically weighing prevalence, detection value, capacity constraints, population risk, and test validity. This structured approach — rather than treating screening as a single yes/no question — demonstrates the kind of layered analytical thinking expected in health policy and epidemiology writing.
Structure breakdown
The paper opens by establishing the general criteria for launching any screening program, then narrows to population selection, then addresses ethical edge cases, and finally evaluates the comparative reliability of available tests. Each paragraph builds directly on the previous, following a funnel structure from broad policy logic to specific clinical considerations. Two peer-reviewed sources are cited in APA format to support the clinical claims.
Criteria for Initiating a Screening Program
Several criteria inform the decision to initiate screening for a disease. The example used here is colorectal cancer. One primary factor is the prevalence of the disease: conditions with relatively high prevalence are more likely to justify screening programs, since mass screening for rare diseases is not necessarily an efficient use of resources. A second consideration is the availability of reliable tests. Colorectal cancer has both relatively high prevalence and a number of reliable diagnostic options, ranging from barium tests to colonoscopy.
The value of early detection is also an important variable. For a disease such as ALS, the prognosis does not change meaningfully with early detection. With colorectal cancer, however, the prognosis improves substantially when polyps or Stage 1 tumors are identified early. A screening program is therefore most justified when a disease has high prevalence, when early detection materially changes outcomes, and when tests capable of early detection exist. In the case of colonoscopy or sigmoidoscopy, capacity constraints — specifically, the limited number of practitioners qualified to perform these procedures — also play a role in program design decisions.
Selecting the Target Population
Once a screening program has been established, the next step is determining which population should be targeted. Ideally, screening is directed at those most at risk of the disease, though other considerations also apply. For colorectal cancer, routine screening is generally recommended for everyone over the age of 50, and is sometimes recommended earlier for individuals with a family history of the disease. For people in these groups, screening programs are typically available through public health channels.
References
Burt, R., Barthel, J., Dunn, K., David, D., Drelichman, E., Ford, J., Giardello, F., Gruber, S., Halverson, A., Hamilton, S., Ismail, M., Jasperson, K., Lazenby, A., Lynch, P., Martin, E., Mayer, R., Ness, R., Provenzale, D., Rao, M., Shike, M., Steinbach, G., Terdimann, J., & Weinberg, D. (2010). Colorectal cancer screening: Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 8(1), 8–60.
Bretthauer, M. (2011). Colorectal cancer screening. Journal of Internal Medicine, 270(2), 87–98.
Already a member? Log in
Unlock the rest of this paper
135,000+ research papers · AI writing tools · Plagiarism & AI detection
24-Hour Pass
Does not renew
Get 24-Hour PassMonthly
Renews at $12.99/month until canceled
Start MonthlyAnnual
Renews at $99/year until canceled
Start Annual- Unlimited AI writing tools
- Plagiarism and AI text detection tool
Plan details
Unlimited AI writing tools are for individual, non-automated use and are subject to our Terms of Service and abuse-prevention measures.
TextChecker scans: 1 during the 24-Hour Pass, or 5 per month with Monthly and Annual.
Prices exclude applicable tax.
Always verify citation format against your institution’s current style guide requirements.